| 5.02 Delayed Data As of Sep 20 |  -0.14 / -2.71%Today’s Change | 4.58 Today|||52-Week Range 12.53 | +1.21% Year-to-Date |
| Previous close | 5.16 |
| Today’s open | 5.10 |
| Day’s range | 4.92 - 5.10 |
| Volume | 17,551,182 |
| Average volume (3 months) | 12,967,532 |
| Market cap | $6.1B |
| Earnings growth (last year) | -271.67% |
| Earnings growth (this year) | +50.02% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +331.06% |
| P/E ratio | NM |
| Price/Sales | 42.58 |
| Price/Book | 1.80 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARGXargenx SE | -1.02 | -0.81% |
| CRONCronos Group Inc | +0.06 | +0.59% |
| APHAAphria Inc | +0.11 | +1.82% |
| USNAUSANA Health Science... | -0.56 | -0.81% |
| Next reporting date | October 28, 2019 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $187.3M |
| Annual profit (last year) | -$219.7M |
| Net profit margin | -117.30% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Terry Booth |
President & Director Steve Dobler |
Corporate headquarters Edmonton, Alberta |
